Ken Griffin Codexis, Inc. Put Options Transaction History

Citadel Advisors LLC

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 14, 2024	SELL	$2.65 - $3.92 $2,120 - $3,136	-800 Reduced 80.0%	200 $0
Q1 2024 May 15, 2024	SELL	$2.59 - $4.65 $777 - $1,395	-300 Reduced 23.08%	1,000 $3,000
Q4 2023 Feb 14, 2024	SELL	$1.54 - $3.37 $1,232 - $2,696	-800 Reduced 38.1%	1,300 $3,000
Q3 2023 Nov 14, 2023	SELL	$1.5 - $3.75 $2,550 - $6,375	-1,700 Reduced 44.74%	2,100 $3,000
Q2 2023 Aug 14, 2023	SELL	$2.21 - $4.43 $31,382 - $62,905	-14,200 Reduced 78.89%	3,800 $10,000
Q1 2023 May 15, 2023	BUY	$3.81 - $6.76 $48,768 - $86,528	12,800 Added 246.15%	18,000 $74,000
Q4 2022 Feb 14, 2023	SELL	$4.26 - $6.84 $22,578 - $36,252	-5,300 Reduced 50.48%	5,200 $24,000
Q3 2022 Nov 14, 2022	BUY	$6.06 - $12.86 $63,629 - $135,030	10,500 New	10,500 $64,000

125

47.9M

33.7K

20.2K

Ticker CDXS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,494,100
Market Cap $266M
Description
Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.